ScripGSK’s Blenrep’s initial regulatory approval as a treatment for second-line relapsed/refractory multiple myeloma, marks just the first big step in what could be a remarkable comeback for the antibody-d
In VivoQuin Wills, an Oxford and Cambridge University alumnus with a DPhil in Statistical Genomics, MSc in Applied and Computational Mathematics, and MPhil in Computational Biology, co-founded Ochre Bio afte
Pink SheetThe Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices sprinted through a condensed two-day schedule at its 15-16 April meeting, which originally had been planne
Pink SheetEU-level joint clinical assessments (JCAs) will apply for vaccines under the HTA Regulation from 2030, but manufacturers are concerned that the framework to be used by assessors is unsuitable for vacc